Stuttgart - Delayed Quote EUR

Novozymes A/S (NZM2.SG)

Compare
54.36 +0.58 (+1.08%)
At close: December 20 at 4:48:10 PM GMT+1
Loading Chart for NZM2.SG
DELL
  • Previous Close 53.78
  • Open 53.58
  • Bid 53.92 x 50000
  • Ask 54.24 x 50000
  • Day's Range 53.44 - 54.36
  • 52 Week Range 46.26 - 64.92
  • Volume 100
  • Avg. Volume 64
  • Market Cap (intraday) 16.33B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 37.59
  • EPS (TTM) 1.45
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. It operates through three divisions: Household Care and Technical Industries, Agriculture and Bioenergy, and Food and Beverages. The company offers solutions for the agriculture industry, including enzymes for animal nutrition to enhance digestion processes; probiotics; microbial solutions to maintain water quality that limits risk of disease and enhances yields in aquaculture; and microbial-based biocontrol and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; enzymes for drug delivery and drug formulation; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and biological wastewater treatment products. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

www.novozymes.com

6,385

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: NZM2.SG

View More

Performance Overview: NZM2.SG

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NZM2.SG
17.65%
OMX Copenhagen 25 Index
4.44%

1-Year Return

NZM2.SG
18.92%
OMX Copenhagen 25 Index
1.93%

3-Year Return

NZM2.SG
23.47%
OMX Copenhagen 25 Index
8.53%

5-Year Return

NZM2.SG
140.13%
OMX Copenhagen 25 Index
40.27%

Compare To: NZM2.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NZM2.SG

View More

Valuation Measures

Annual
As of 12/19/2024
  • Market Cap

    25.13B

  • Enterprise Value

    26.86B

  • Trailing P/E

    57.74

  • Forward P/E

    26.60

  • PEG Ratio (5yr expected)

    0.23

  • Price/Sales (ttm)

    6.46

  • Price/Book (mrq)

    2.27

  • Enterprise Value/Revenue

    8.81

  • Enterprise Value/EBITDA

    56.55

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.90%

  • Return on Assets (ttm)

    13.79%

  • Return on Equity (ttm)

    26.46%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    443.42M

  • Diluted EPS (ttm)

    1.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    107.64M

  • Total Debt/Equity (mrq)

    16.85%

  • Levered Free Cash Flow (ttm)

    232.8M

Research Analysis: NZM2.SG

View More

Company Insights: NZM2.SG

Research Reports: NZM2.SG

View More